LOW-VOLUME · HOSP-HEAVY
acamprosate Side Effects
acamprosate (also sold as Campral) is a LOW-VOLUME FAERS extract #513 of 524 by FAERS report count. Still opens on HOSP-HEAVY: 48.2% mention hospitalization (144 reports).
Data updated 2026-05-15
- 299
- FAERS reports
Thinner FAERS book - still a temporal association ledger, not proof of cause. Methodology.
acamprosate: 48.2% mention hospitalization (144 reports). Death stamp DEATH-HEAVY; volume band LOW-VOLUME #513 of 524 by FAERS report count.
Thinner FAERS extract for acamprosate (Campral) (299 reports #513 of 524 by FAERS report count). 48.2% mention hospitalization (144 reports). Sparse books still carry named reaction rows when present; not medical advice.
Counts from the openFDA FAERS extract (2006–2025). Stamps TRACE-CASE · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
HYPOTENSION leads 14 of 299 reports
Who reports · age peak 45-64 (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 45-64 (113 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (25 reports, 8.4%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| TOXICITY TO VARIOUS AGENTS | 8 |
| COMPLETED SUICIDE | 6 |
| DEATH | 5 |
| INTERSTITIAL LUNG DISEASE | 3 |
| CARDIAC ARREST | 2 |
| GASTROINTESTINAL HAEMORRHAGE | 2 |
| ASPHYXIA | 1 |
| CARDIO-RESPIRATORY ARREST | 1 |
| CIRCULATORY COLLAPSE | 1 |
| DRUG TOXICITY | 1 |
| INTENTIONAL OVERDOSE | 1 |
| MULTIPLE DRUG OVERDOSE INTENTIONAL | 1 |
| SUICIDE ATTEMPT | 1 |
| TRANSPLANT | 1 |
Reactions in Hospitalization Reports
Hospitalization is HEAVY (144, 48.2% of the book). Top reactions in those rows:
| Reaction | Reports |
|---|---|
| ACUTE KIDNEY INJURY | 12 |
| CONDITION AGGRAVATED | 11 |
| COMA | 10 |
| CYTOLYTIC HEPATITIS | 9 |
| DRUG ABUSE | 9 |
| HYPOGLYCAEMIA | 9 |
| HYPOTENSION | 9 |
| OVERDOSE | 9 |
| ATRIOVENTRICULAR BLOCK | 8 |
| BRADYCARDIA | 8 |
| ALCOHOL WITHDRAWAL SYNDROME | 7 |
| DEPRESSION | 7 |
| DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS | 7 |
| FATIGUE | 7 |
| HEPATIC CYTOLYSIS | 7 |
| RESPIRATORY DISTRESS | 7 |
| TACHYCARDIA | 7 |
| AGITATION | 6 |
| ASTHENIA | 6 |
| CHOLESTASIS | 6 |
How to read acamprosate FAERS figures (TRACE-CASE · DEATH-HEAVY · HOSP-HEAVY)
FAERS holds 299 voluntary reports linked to acamprosate (Campral), 2006-2025. Death is listed on 25 (8.4%). Hospitalization appears on 144 (48.2%). Top co-reported indication: Product Used For Unknown Indication.
Sparse extract - named reactions and SEX-BALANCED skew still differ by drug; not a complete safety profile.
Read with acamprosate
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-HEAVY stamps.
ABS(total_reports) peer at 318 FAERS cases (Δ 19 heavier vs acamprosate); DEATH-MARKED · HOSP-MID · FEMALE-LED vs this page's TRACE-CASE · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 278 FAERS cases (Δ 21 lighter vs acamprosate); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's TRACE-CASE · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 329 FAERS cases (Δ 30 heavier vs acamprosate); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's TRACE-CASE · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 218 FAERS cases (Δ 81 lighter vs acamprosate); DEATH-MARKED · HOSP-HEAVY · SEX-BALANCED vs this page's TRACE-CASE · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 53.7 pp vs acamprosate's DEATH-HEAVY): CASELOAD · HOSP-MID.
acamprosate stamps DEATH-HEAVY · HOSP-HEAVY; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload TRACE-CASE and the label guide.